Compliance
Homeopathy’s Path Ahead: 5 Ways We’re Moving the Needle Together
A glance at AAHP and HPCUS’ multi-year, industry-wide initiative to clarify ambiguities in homeopathic manufacturing. Homeopathy’s path forward is a collective effort between manufacturers, scientists, homeopathic practitioners, and regulators.…
Read MoreThe Importance of AAHP’s 2021 Summit
Implementing HPUS Guidelines for FDA Compliance, Part 2 By Mark Land, AAHP President AAHP’s newsletter editor asked me to write an article explaining the importance of the upcoming…
Read MoreHomeopathic Pharmacopoeia Convention Activities 2020–2021
In early May, Eric Foxman, AAHP Secretary and Senior Scientist with HCPUS, presented a webinar on updates and activities of the Homeopathic Pharmacopoeia Convention of the United States. He noted…
Read MoreFDA Eyes Improvements to Nonprescription Drug Labeling
What impact will that have on your products? The top line: Two years after issuing draft guidance on “innovative” nonprescription drug labeling, FDA is again thinking about potential improvements to…
Read MoreAAHP Disclaimer: Continuing to Deliver Value After Five Years
The AAHP disclaimer, “Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated,” benefits from the best support among disclaimers I have seen – Use It! …
Read MoreAAHP Disclaimer Helps Win Two Lawsuits
Advancing Goal of Informing Consumers & Protecting Sellers By Alvin J. Lorman, Association Counsel If you’ve wondered whether the American Association of Homeopathic Pharmacists’ (AAHP) recommended consumer label…
Read MoreYour Reputation Precedes You
By Mark Land, AAHP President | Brian Westerlind, Editor of the Network News, writes in his article on warning letters – “Each day AAHP works to promote excellence in the practice of homeopathic manufacturing. While achieving true excellence is a lofty goal, it begins with a few simple principles you can start to implement today.”
Read More4 Simple Ways to Keep Your Homeopathic Manufacturing Process Safe and Effective
Each day AAHP works to promote excellence in the practice of homeopathic manufacturing. While achieving true excellence is a lofty goal, it begins with a few simple principles you can start to implement today.
We’ve reviewed recent Warning Letters from the U.S. FDA—which highlight some of the most common missteps and shortcomings—and have put together these four basic ground rules that can help any homeopathic manufacturer or marketer strive toward excellence.
Read MorePoison Control Center Statistics on Homeopathy
What’s Your Company’s Safety Statistics? When FDA announced its public hearing on homeopathy, the agency cited 10,311 reported poison exposure cases related to “homeopathic agents” in the 2012 American…
Read MoreWhat is the HPUS and Who Creates It?
By Eric L. Foxman, R.Ph., senior scientist, HPCUS Homeopathic pharmacopoeias have been published continually since the 1840s. The Homeopathic Pharmacopoeia of the United States (HPUS) has been in continuous publication…
Read More